FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to pulmonology, and can be used in treatment of bronchial asthma ensured by daily inhalations of aerosol melphalan solution with inert gas dosed 10-90 mkg within 3-4 days. Treatment session at least 4 in number is repeated every 5-6 months.
EFFECT: developed regimen of ultralow-dosed preparation introduction allows maintaining therapeutic effect over a long period of time.
2 ex
Title | Year | Author | Number |
---|---|---|---|
TREATMENT OF PATIENTS SUFFERING FROM BRONCHIAL ASTHMA | 2008 |
|
RU2356574C1 |
PREPARATION FOR TREATMENT OF BRONCHIAL ASTHMA AND METHOD FOR ITS TREATMENT | 2000 |
|
RU2162322C1 |
METHOD OF TREATMENT OF STEROID-DEPENDENT BRONCHIAL ASTHMA | 2007 |
|
RU2348431C1 |
METHOD OF TREATMENT OF STEROID-DEPENDENT BRONCHIAL ASTHMA | 1987 |
|
RU2028083C1 |
METHOD FOR TREATMENT OF ASTHMA | 2015 |
|
RU2611406C1 |
METHOD OF TREATMENT OF BRONCHIAL ASTHMA | 2017 |
|
RU2652752C1 |
METHOD OF ACHIEVING CONTROL OVER BRONCHIAL ASTHMA | 2013 |
|
RU2571894C2 |
METHOD FOR TREATING THE CASES OF BRONCHIAL ASTHMA | 1994 |
|
RU2114653C1 |
METHOD OF DIFFERENTIAL DIAGNOSTICS OF BRONCHIAL ASTHMA | 2008 |
|
RU2391663C1 |
METHOD FOR PREDICTION OF AGGRAVATED BRONCHIAL ASTHMA DURATION | 2010 |
|
RU2446400C1 |
Authors
Dates
2009-05-27—Published
2008-04-21—Filed